NOT-CA-22-101: Notice of NCI's Participation in Notice of Special Interest: Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional)

Notice of NCI's Participation in “Notice of Special Interest: Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional)”

Notice Number:

NOT-CA-22-101

Key Dates

Release Date:

June 16, 2022

Related Announcements

NOT-OD-22-140 - Notice of Special Interest: Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating, effective immediately, in NOT-OD-22-140, “Notice of Special Interest: Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional).”

The following sections of NOT-OD-22-140 have been modified to reflect NCI's participation in this FOA.

Issued by

Office of Behavioral and Social Sciences Research (OBSSR)

National Institute on Aging (NIA)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute on Minority Health and Health Disparities (NIMHD)

Modified to Read (changes shown in bold italics):

Issued by

Office of Behavioral and Social Sciences Research (OBSSR)

National Institute on Aging (NIA)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute on Minority Health and Health Disparities (NIMHD)

National Cancer Institute (NCI)

Inquiries

Please direct all inquiries to:

David Dean Jr., Ph.D., M.S.,
National Cancer Institute (NCI)
Telephone: 240-276-7803
Email: [email protected]